Table 1.
Country | Number of data | Reporting unit | Specimens for measuring viral load | Date of collection | Source |
---|---|---|---|---|---|
Symptomatic | |||||
USA | viral load (copies/mL) | Nares and oropharyngeal swabs | Nov 2020 to May 2021 | ref. 44 | |
USA | viral load (copies/mL) | Nares and oropharyngeal swabs | Nov 2020 to May 2021 | ref. 26 | |
Germany | viral load (copies/swab)b | Pharyngeal swab | Jan 2020 | ref. 19 | |
Korea | cycle thresholda | Oro/nasopharyngeal swabs | May 2020 | ref. 45 | |
Korea | cycle thresholda | Oro/nasopharyngeal swab | Feb 2020 | ref. 46 | |
Singapore | cycle thresholda | Nasopharyngeal swab | Jan to Feb 2020 | ref. 47 | |
China | cycle thresholda | Nasal swab | Jan 2020 | ref. 48 | |
Asymptomatic | |||||
USA | viral load (copies/mL) | Nares and oropharyngeal swabs | Nov 2020 to May 2021 | ref. 44 | |
USA | viral load (copies/mL) | Nares and oropharyngeal swab | Nov 2020 to May 2021 | ref. 26 | |
Japan | cycle thresholda | Nasopharyngeal or throat swab | Jan 2020 | ref. 49 | |
Korea | cycle thresholda | Nasal and throat swabs | Feb to Apr 2020 | ref. 50 | |
Singapore | cycle thresholda | Nasopharyngeal swab | Mar to Apr 2020 | ref. 51 |
aViral load was calculated from cycle threshold values using the conversion formula: 22.
b1 swab = 3 mL.